Baird Medical Investment Holdings Limited
BDMD
$3.14
$0.051.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 17.74% | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 17.74% | -- | -- | -- | |
| Cost of Revenue | 3.69% | -- | -- | -- | |
| Gross Profit | 19.92% | -- | -- | -- | |
| SG&A Expenses | 0.64% | -- | -- | -- | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 10.85% | -- | -- | -- | |
| Operating Income | 29.11% | -- | -- | -- | |
| Income Before Tax | 13.98% | -- | -- | -- | |
| Income Tax Expenses | -12.45% | -- | -- | -- | |
| Earnings from Continuing Operations | 18.20% | -- | -- | -- | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -28.88% | -- | -- | -- | |
| Net Income | 18.09% | -- | -- | -- | |
| EBIT | 29.11% | -- | -- | -- | |
| EBITDA | 27.79% | -- | -- | -- | |
| EPS Basic | 13.94% | -- | -- | -- | |
| Normalized Basic EPS | 10.27% | -- | -- | -- | |
| EPS Diluted | 14.74% | -- | -- | -- | |
| Normalized Diluted EPS | 9.79% | -- | -- | -- | |
| Average Basic Shares Outstanding | 0.00% | -- | -- | -- | |
| Average Diluted Shares Outstanding | 0.29% | -- | -- | -- | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |